-
NEWS
BD Names Gregory J. Hayes to Board of DirectorsLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26,...
-
NEWS
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision SurgeryLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial...
-
BLOG
Together We AdvanceWe are proud to share a report of impact and progress made toward the goals and commitments we set for 2030+ to advance the health of our company, planet, communities and people.Learn More